Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis

General Physiology and Biophysics

Volumn 28, Issue , 2009, Pages

  Sulová, Zdenka ^a   Šereš, Mário ^a   Barančík, Miroslav ^a   Gibalová, Lenka ^a   Uhrik, Branislav ^a   Poleková, Lenka ^a   Breier, Albert ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

Ca2+ antagonists; Calcium binding proteins; Calcium homeostasis; Endoplasmic reticulum; P gp mediated MDR

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ARTEMISININ; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALMODULIN; CALMODULIN INHIBITOR; CALNEXIN; DILTIAZEM; FANTOFARONE; FLUNARIZINE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; NIFEDIPINE; NIMODIPINE; PARTHENOLIDE; SORCIN; THAPSIGARGIN; TRIFLUOPERAZINE; VERAPAMIL; VINCRISTINE;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CONFERENCE PAPER; DRUG ACTIVITY; EFFUSION; ENDOPLASMIC RETICULUM; GENE OVEREXPRESSION; HUMAN; MULTIDRUG RESISTANCE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CALCIUM; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MODELS, BIOLOGICAL; P-GLYCOPROTEIN;

EID: 77149173437     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Anthony D. F., Beattie J., Paul A., Currie S. (2007): Interaction of calcium/calmodulin-dependent protein kinase IIdeltaC with sorcin indirectly modulates ryanodine receptor function in cardiac myocytes. J. Mol. Cell. Cardiol. 43, 492-503
2. Axiotis C. A., Bani D., Bianchi S., Pioli P., Tanini A., Brandi M. L. (1995): P-glycoprotein is expressed in parathyroid epithelium and is regulated by calcium. Calcif. Tissue Int. 56, 170-174
3. 2+-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemic cell line. Drugs Exp. Clin. Res. 20, 13-18
4. Breier A., Barancik M., Sulova Z., Uhrik B. (2005): P-glycoprotein - implications of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets 5, 457-468
5. Breier A., Drobna Z., Docolomansky P., Barancik M. (2000): Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study. Neoplasma 47, 100-106
6. Brezden C. B., Hedley D. W., Rauth A. M. (1994): Constitutive expression of P-glycoprotein as a determinant of loading with fluorescent calcium probes. Cytometry 17, 343-348
7. Didziapetris R., Japertas P., Avdeef A., Petrauskas A. (2003): Classification analysis of P-glycoprotein substrate specificity. J. Drug. Target 11, 391-406
8. Egan M. E., Glockner-Pagel J., Ambrose C., Cahill P. A., Pappoe L., Balamuth N., Cho E., Canny S., Wagner C. A., Geibel J., Caplan M. J. (2002): Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8, 485-492
9. Eneroth A., Astrom E., Hoogstraate J., Schrenk D., Conrad S., Kauffmann H. M., Gjellan K. (2001): Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur. J. Pharm. Sci. 12, 205-214
10. Fiala R., Sulova Z., El-Saggan A. H., Uhrík B., Liptaj T., Dovinova I., Hanusovska E., Drobna Z., Barancik M., Breier A. (2003): P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligoand/or polysaccharide contents. Biochim. Biophys. Acta 1639, 213-224
11. Ford J. M. (1996): Experimental reversal of P-glycoprotein-medi-ated multidrug resistance by pharmacological chemosensitisers. Eur. J. Cancer 32A, 991-1001
12. 2+ current inactivation by sorcin in isolated rabbit cardiomyocytes. Pflugers Arch. 457, 1049-1060
13. 2+ current by functional interaction with the alpha 1C subunit in rabbits. Exp. Physiol. 93, 1233-1238
14. Fu L. W., Pan Q. C., Lin G. Y. (1997): Compared study on Fura-2/AM assay and MTT assay for screening multidrug resistant modulators. Yao Xue Xue Bao 32, 401-405 (in Chinese)
15. Fu L. W., Zhang Y. M., Liang Y. J., Yang X. P., Pan Q. C. (2002): The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer 38, 418-426
16. Ganapathi R., Kamath N., Constantinou A., Grabowski D., Ford J., Anderson A. (1991): Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells. Biochem. Pharmacol. 41, R21-R26
17. Grubb B. R., Gabriel S. E., Mengos A., Gentzsch M., Randell S. H., Van Heeckeren A. M., Knowles M. R., Drumm M. L., Riordan J. R., Boucher R. C. (2006): SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 34, 355-363
18. 2+ transport ATPase and P-glycoprotein expression can mediate resistance to thapsigargin. J. Biol. Chem. 269, 7976-7981
19. Hollt V., Kouba M., Dietel M., Vogt G. (1992): Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. Biochem. Pharmacol. 43, 2601-2608
20. Jaffrezou J. P., Herbert J. M., Levade T., Gau M. N., Chatelain P., Laurent G. (1991): Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein. J. Biol. Chem. 266, 19858-19864
21. Karaszi E., Jakab K., Homolya L., Szakacs G., Hollo Z., Telek B., Kiss A., Rejto L., Nahajevszky S., Sarkadi B., Kappelmayer J. (2001): Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. Br. J. Haematol. 112, 308-314
22. Kawakami M., Nakamura T., Okamura N., Komoto C., Markova S., Kobayashi H., Hashimoto N., Okumura K., Sakaeda T. (2007): Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells. Biol. Pharm. Bull. 30, 1065-1073
23. Kimura Y., Matsuo M., Takahashi K., Saeki T, Kioka N., Amachi T., Ueda K. (2004): ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein. Curr. Drug Metab. 5, 1-10
24. Loo T. W., Bartlett M. C., Clarke D. M. (2004): Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. Biochem. Biophys. Res. Commun. 325, 580-585
25. Loo T. W., Clarke D. M. (1994): Prolonged association of temperature-sensitive mutants of human P-glycoprotein with calnexin during biogenesis. J. Biol. Chem. 269, 28683-28689
26. Mestdagh N., Vandewalle B., Hornez L., Henichart J. P. (1994): Comparative study of intracellular calcium and adenosine 3′,5′- cyclic monophosphate levels in human breast carcinoma cells sensitive or resistant to Adriamycin: contribution to reversion of chemoresistance. Biochem. Pharmacol. 48, 709-716
27. O'Neill J. P., Velalar C. N., Lee D. I., Zhang B., Nakanishi T., Tang Y., Selaru F., Ross D., Meltzer S. J., Hussain A. (2006): Thapsigargin resistance in human prostate cancer cells. Cancer 107, 649-659
28. Orlicky J., Sulova Z., Dovinova I., Fiala R., Zahradnikova A. Jr., Breier A. (2004): Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopy. Gen. Physiol. Biophys. 23, 357-366
29. Papp B., Brouland J. P., Gelebart P., Kovacs T., Chomienne C. (2004): Endoplasmic reticulum calcium transport AT-Pase expression during differentiation of colon cancer and leukaemia cells. Biochem. Biophys. Res. Commun. 322, 1223-1236
30. Parekh H. K., Deng H. B., Choudhary K., Houser S. R., Simpkins H. (2002): Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem. Pharmacol. 63, 1149-1158
31. Pawagi A. B., Wang J., Silverman M., Reithmeier R. A., Deber C. M. (1994): Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity. J. Mol. Biol. 235, 554-564
32. Riganti C., Campia I., Polimeni M., Pescarmona G., Ghigo D., Bosia A. (2009a): Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1 alpha in human colon cancer cells. Toxicol. Appl. Pharmacol. 240, 385-392
33. Riganti C., Doublier S., Viarisio D., Miraglia E., Pescarmona G., Ghigo D., Bosia A. (2009b): Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression. Br. J. Pharmacol. 156, 1054-1066
34. Safa A. R. (1988): Photoaffinity labeling of the multidrug-resistance- related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. U.S.A. 85, 7187-7191
35. 2+-calmodulin. J. Biol. Chem. 270, 11040-11042
36. Seres M., Polakova E., Krizanova O., Hudecova S., Klymenko S. V., Breier A., Sulova Z. (2008): Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity. Gen. Physiol. Biophys. 27, 211-221
37. Shapiro A. B., Ling V. (1994): ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Chem. 269, 3745-3754
38. Shin S. Y., Choi B. H., Kim J. R., Kim J. H., Lee Y. H. (2006): Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells. Eur. J. Pharm. Sci. 28, 300-306
39. Sugawara I., Mizumoto K., Ohkochi E., Hamada H., Tsuruo T., Mori S. (1989): Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line. Jpn. J. Cancer Res. 80, 469-474
40. Sulova Z., Macejova D., Seres M., Sedlak J., Brtko J., Breier A. (2008): Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Toxicol. In Vitro 22, 96-105
41. Sulova Z., Mislovicova D., Gibalova L., Vajcnerova Z., Polakova E., Uhrik B., Tylkova L., Kovarova A., Sedlak J., Breier A. (2009): Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides. J. Proteome Res. 8, 513-520
42. 2+. Biochem. Biophys. Res. Commun. 335, 777-784
43. 2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression. Eur. J. Pharm. Sci. 16, 159-165
44. Tan Y., Li G., Zhao C., Wang J., Zhao H., Xue Y., Han M., Yang C. (2003): Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk. Res. 27, 125-131
45. Van Acker K. L., De Greef C., Eggermont J., Zhang P., Vandenberghe P., Boogaerts M. A. (1995): Detection of P-glycoprotein with a rapid flow cytometric functional assay using Fluo-3: evaluation of sensitivity, specificity and feasibility in multiparametric analysis. Leukemia 9, 1398-1406
46. Wagner-Souza K., Echevarria-Lima J., Rodrigues L. A., Reis M., Rumjanek V. M. (2003): Resistance to thapsigargin-induced intracellular calcium mobilization in a multidrug resistant tumour cell line. Mol. Cell. Biochem. 252, 109-116
47. Witkowski J. M., Miller R. A. (1999): Calcium signal abnormalities in murine T lymphocytes that express the multidrug transporter P-glycoprotein. Mech. Ageing Dev. 107, 165-180
48. 2+ pumps. Biosci. Rep. 15, 299-306
49. Zhou S. F. (2008): Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38, 802-832